Name

Diane Lougheed

CTS Affiliation
Asthma Clinical Assembly (Chair) Canadian Respiratory Guidelines Committee

Disclosure
Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). In-Kind Support: Pharmaxis Ltd. (donation of dry-powder mannitol for research) Peer Reviewed Funding: Ontario Thoracic Society Research Funding: Allergen NCE, Ception Therapeutics Inc., GlaxoSmithKline, MPEX, S Queens University, Schering-Plough, Government of Ontario Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Advisor: Qubec Institut national dexcellence en sant et en services sociaux (INNESS) Advisory Board/Membership: AstraZeneca,GlaxoSmithKline, Novartis, Quebec Workmens Compensation Board, Canadian Network of Centres of Excellence AllerGen Clinical Investigators Collaborative, Laval University Knowledge Transfer, Prevention and Education in Respiratory and Cardiovascular Health (Chair), Quebec Research Network Knowledge Transfer Platform (Chair), Global Initiative for Asthma (GINA) Dissemination and Implementation Committee (Chair) Research Funding: Amgen, AsthmaTx, AsthmaCure, AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Genentech, MedImmune, Novartis, Pharmaxis, Roche, Wyeth Speaker/Honoraria: Altana, AstraZeneca, GlaxoSmithKline, Merck-Frosst, Novartis Sponsorship (investigator-generated research): AstraZeneca, GlaxoSmithKline, Merck-Frosst, Schering-Plough, Novartis Support for Educational Materials: AstraZeneca, GlaxoSmithKline, MerckFrosst

Updated
November 3, 2011

Louis-Philippe Boulet

Asthma Clinical Assembly Canadian Respiratory Guidelines Committee (Chair)

October 30, 2011

Name
Sharon Dell

CTS Affiliation
Asthma Clinical Assembly

Disclosure
Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Speaker/Honoraria: Novartis, Merck-Frosst, Nycomed, GlaxoSmithKline Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Research Grant: Merck and Co. USA Unrestricted Grant: Novartis Canada, Merck-Frosst Canada, Nycomed Canada Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Advisory Board/Membership: A-2, B-1, Boehringer Ingelheim,GlaxoSmithKline, Nycomed, Novartis, Merck, Pfizer, Global Initiative for Asthma (GINA) Executive, Science Committee (Chair) Peer Reviewed Funding: CIHR, BC Lung Association, Michael Smith Foundation for Health Research, Worksafe BC, National Sanitarium Association Research Funding: A-2, B-1, GlaxoSmithKline, Merck, Novartis, Pharmaxis, Genentech Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Academia: GSK-CIHR Professorship in Inflammatory Lung Disease (University of Calgary) Advisory Board: GlaxoSmithKline, Merck, Novartis Research Funding: CIHR, Alberta Innovates-Health Solutions, AstraZeneca, Genentech, GlaxoSmithKline, MedImmune, Pharmaxis, Centocor Speaker/Honoraria: AstraZeneca, GlaxoSmithKline, Merck, Novartis

Updated
October 30, 2011

Francine Ducharme

Asthma Clinical Assembly

October 30, 2011

Mark FitzGerald

Asthma Clinical Assembly

October 30, 2011

Richard Leigh

Asthma Clinical Assembly CTS Research Committee

October 30, 2011

Name
Catherine Lemiere

CTS Affiliation
Asthma Clinical Assembly

Disclosure
Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Advisor: AstraZeneca, Merck, Novartis, GlaxoSmithKline Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Advisory Board: AstraZeneca Canada National Respiratory Advisory Board Research Funding: Novartis Canada Speaker/Honoraria: AstraZeneca, GlaxoSmithKline, Pfizer Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Research Funding: GlaxoSmithKline, MedImmune Over the last two years, I have had affiliations (financial or otherwise) with a commercial or other organization that could or has led to a real or perceived conflict of interest(s). Advisory Board/Membership: King Pharma, Canadian Society of Allergy & Clinical Immunology

Updated
October 31, 2011

Christopher Licskai

Brian Rowe

Asthma Clinical Assembly Canadian Respiratory Guidelines Committee Asthma Clinical Assembly

November 22, 2011

October 30, 2011

Wade Watson

Asthma Clinical Assembly

October 30, 2011